Cerebral sponginess and GM3 gangliosidosis; ultrastructure and probable pathogenesis.
Tanaka J, Garcia JH, Max SR, Viloria JE, Kamijyo Y, McLaren NK, Cornblath M, Brady RO.
J Neuropathol Exp Neurol. 1975 May;34(3):249-62. doi: 10.1097/00005072-197505000-00003.
GM2 gangliosidosis AB variant: first case of late onset and review of the literature.
Ganne B, Dauriat B, Richard L, Lamari F, Ghorab K, Magy L, Benkirane M, Perani A, Marquet V, Calvas P, Yardin C, Bourthoumieu S.
Neurol Sci. 2022 Nov;43(11):6517-6527. doi: 10.1007/s10072-022-06270-x. Epub 2022 Aug 4.
Gangliosides in nervous system development, regeneration, and pathologies.
Vasques JF, de Jesus Gonçalves RG, da Silva-Junior AJ, Martins RS, Gubert F, Mendez-Otero R.
Neural Regen Res. 2023 Jan;18(1):81-86. doi: 10.4103/1673-5374.343890.
Plasma G(M2) ganglioside potential biomarker for diagnosis, prognosis and disease monitoring of GM2-Gangliosidosis.
Blondel A, Kraoua I, Marcelino C, Khrouf W, Schlemmer D, Ganne B, Caillaud C, Fernández-Eulate G, Turki IBY, Dauriat B, Bonnefont-Rousselot D, Nadjar Y, Lamari F.
Mol Genet Metab. 2023 Feb;138(2):106983. doi: 10.1016/j.ymgme.2022.106983. Epub 2022 Dec 26.
GM3 gangliosidosis: a novel human sphingolipodystrophy.
Maclaren NK, Max SR, Cornblath M, Brady RO, Ozand PT, Campbell J, Rennels M, Mergner WJ, Garcia JH.
Pediatrics. 1976 Jan;57(1):106-10.
Characterization of a phenotypically severe animal model for human AB-Variant GM2 gangliosidosis.
Deschenes NM, Cheng C, Khanal P, Quinville BM, Ryckman AE, Mitchell M, Pshezhetsky AV, Walia JS.
Front Mol Neurosci. 2023 Nov 30;16:1242814. doi: 10.3389/fnmol.2023.1242814. eCollection 2023.
Regulation of GM2 ganglioside metabolism in cultured cells.
Dawson G, Hancock LW, Vartanian T.
Chem Phys Lipids. 1986 Dec 15;42(1-3):105-16. doi: 10.1016/0009-3084(86)90046-0.
Natural history of Tay-Sachs disease in sheep.
Story B, Taghian T, Gallagher J, Koehler J, Taylor A, Randle A, Nielsen K, Gross A, Maguire A, Carl S, Johnson S, Fernau D, Diffie E, Cuddon P, Corado C, Chandra S, Sena-Esteves M, Kolodny E, Jiang X, Martin D, Gray-Edwards H.
Mol Genet Metab. 2021 Sep-Oct;134(1-2):164-174. doi: 10.1016/j.ymgme.2021.08.009. Epub 2021 Aug 21.
Gangliosides enhance apoptosis of thymocytes.
Zhou J, Shao H, Cox NR, Baker HJ, Ewald SJ.
Cell Immunol. 1998 Feb 1;183(2):90-8. doi: 10.1006/cimm.1998.1247.
[The metabolism of radiolabelled GM1-ganglioside in cultured skin fibroblasts from controls and patients with GM1-gangliosidosis].
Inui K.
Nihon Rinsho. 1995 Dec;53(12):3102-4.
